In support of this notion, ATM missense substitutions seem to be more prevalent among Swedish, Canadian and Slovenian breast cancer patients (Dörk et al, 2001) and among US heterogeneous women (Teraoka et al, 2001). The gene discussed is ATM; the disease is breast carcinoma.